Remote Technology: What is Your Plan?
Amid the disruptions of the pandemic, telehealth, mobile health (mHealth), and remote patient monitoring (RPM) have become vital to both patients and providers. Entry requirements may be reduced right now, but you will have to prove your validity and value in the near future. Do you have a plan to get the data you need?
In efforts to reduce exposure risk and redirect resources to treating COVID-19, healthcare professionals are increasing adoption of innovative forms of patient care:
- Telehealth appointments are allowing doctors to provide medical care while eliminating potential exposure.
- Monitoring patient lung and heart function, breathing, blood pressure, and other factors remotely is allowing facilities to preserve hospital beds for severe COVID-19 patients.
- mHealth applications are providing asymptomatic COVID-19 patients and symptomatic COVID-19 patients not requiring hospitalization with prevention techniques, symptom management, mental health support, and monitoring by healthcare professionals.
Increased adoption due to COVID-19 represents a unique opportunity for medtech companies to collect the data now that they will need to create compelling value propositions for sustained (and increased) adoption later. When the current crisis subsides, remote options will be highly sought after – but in a highly crowded market. The companies who will succeed long-term are the ones planning now to demonstrate, prove and communicate their validity and value to the marketplace.
At TTi, we have extensive experience in supporting remote technologies – we’ve helped accelerate market access opportunities for top device manufacturers across mHealth, telehealth, AI algorithms, SaaS, and more.
Case Study: ROI Tool – Payer Playbook for Evaluating CE of Mobile Health Application
Our client needed to enable health plans to easily evaluate the ROI and impact of their mobile health application for reducing risk of certain conditions such as Type 2 diabetes and heart disease on their populations in terms of both clinical and economic endpoints. Users and prospective users of the client’s mHealth application were requesting ROI analysis support requiring expertise in healthcare claims data beyond what the client had internally. After conducting interviews with key stakeholders, TTi developed a user “playbook” – standardized and generalizable for a variety of users (e.g. healthcare payors, larger employers) – inclusive of cost, outcomes, and programmatic data. The client was able to maximize market access opportunities by easily assisting existing and prospective users in evaluation of ROI and cost-effectiveness of their program.